MDR Transitional periods amendment

The European Parliament voted YES to MDR transitional provisions for certain medical devices and in vitro diagnostic medical devices.

The European Parliament voted YES to MDR transitional provisions for certain medical devices and in vitro diagnostic medical devices.
February 17, 2023

The extended transition period applies only to ‘legacy devices’, i.e., those covered by a certificate or declaration of conformity issued under Council Directives 90/385/EEC or 93/42/EEC before May 26, 2021, as in:

IMPLANTABLE CLASS IIb and CLASS III Devicesà December 31, 2027

WELL-ESTABLISHED CLASS IIb*, CLASS IIa, CLASS Im, Is and Ir DEVICESà December 31, 2028. (*Sutures, staples, dental fillings, dental braces, tooth crowns, screws, wedges, plates, wires, pins, clips and connectors).Furthermore, this provision adapts Articles 122 and 123 MDR to reflect the extended transition period and the 𝗱𝗲𝗹𝗲𝘁𝗶𝗼𝗻 of the ‘𝘀𝗲𝗹𝗹-𝗼𝗳𝗳’ deadline.

The provision also includes amendments in Articles 110(4) and 112 of the IVDR. As a result, IVD devices placed on the market before 26 May, 2022 can be made further available on the market and put into service without a legal time restriction.

What´s next? The transition will become law as soon as it is published in the European journal.

For further information, you can contact us at: [email protected]

 

 

 

Search News & Events

  • Filter by category

Share

Related news and events

EVENT | DIA RAPS Regulatory Policy Forum

Many key takeaways and highlights from the DIA RAPs Regulatory Policy Forum!! Capitalizing on the success of their joint collaboration this past January for 2024 Combination Products in the EU, DIA and the Regulatory Affairs Professionals Society (RAPS) are coming together once again to produce the 2024 Regulatory Policy Forum.
Designed specifically for regulatory policy leaders, senior decision makers, and regulators across the pharmaceutical community, this summit will explore the new EU pharmaceutical legislation and how it will shape the future of the pharmaceutical arena—including research, development and manufacturing—in Europe for decades to come.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting